herceptin
New Treatment Target Identified for Aggressive Breast Cancer
| Marc Maligalig | | Oct 15, 2014 02:12 PM EDT |
Scientists have found that Erbin, a protein that was thought to be an anti-tumor factor, is highly expressed in breast cancer and is needed by ErbB2 to support breast cancer.
Breast Cancer Drug Perjeta Can Prolong Cancer Patients' Lives by 16 Months
| Ana Verayo | | Sep 29, 2014 07:54 AM EDT |
According to a new study, Roche's Perjeta along with chemotherapy and Herceptin can prolong breast cancer patients' lives.
Advertisement
Subscribe to CHINATOPIX !
Sign up for our free weekly newsletter for the latest in-depth coverage!
EDITOR'S PICKS
-
Did the Trump administration just announce plans for a trade war with ‘hostile’ China and Russia?
-
US Senate passes Taiwan travel bill slammed by China
-
As Yan Sihong’s family grieves, here are other Chinese students who went missing abroad. Some have never been found
-
Beijing blasts Western critics who ‘smear China’ with the term sharp power
-
China Envoy Seeks to Defuse Tensions With U.S. as a Trade War Brews
-
Singapore's Deputy PM Provides Bitcoin Vote of Confidence Amid China's Blanket Bans
-
China warns investors over risks in overseas virtual currency trading
-
Chinese government most trustworthy: survey
-
Kashima Antlers On Course For Back-To-Back Titles
Advertisement
MOST POPULAR
Advertisement
LATEST NEWS
Zhou Yongkang: China's Former Security Chief Sentenced to Life in Prison
China's former Chief of the Ministry of Public Security, Zhou Yongkang, has been given a life sentence after he was found guilty of abusing his office, bribery and deliberately ... Full Article
Advertisement
TRENDING STORY
China Pork Prices Expected to Stabilize As The Supplies Recover
-
Elephone P9000 Smartphone is now on Sale on Amazon India
-
There's a Big Chance Cliffhangers Won't Still Be Resolved When Grey's Anatomy Season 13 Returns
-
Supreme Court Ruled on Samsung vs Apple Dispute for Patent Infringement
-
Microsoft Surface Pro 5 Rumors and Release Date: What is the Latest?
Advertisement
